EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols

Tatiana Budagova, Anna Efremova, Natalia Usman iD, Diana Mokrousova, Dmitry Goldshtein

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tatiana Budagova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moskvorechye Str. 1, Moscow 115522, Russia. Hauptthemen laut MEDLINE: Killer Cells, Natural, Induced Pluripotent Stem Cells, Cell Differentiation, Immunotherapy, Adoptive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute of Molecular and Cellular Medicine, Peoples’ Friendship University of Russia, the state assignment of the Federal State Funded Research Institution “Research Centre for Medical Genetics”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancers constitute a leading cause of mortality. Chimeric antigen receptor (CAR) cell therapies provide breakthrough solutions for various cancers while posing considerable risks of immunological side reactions. Of various cytotoxic lymphocyte subsets, natural killer (NK) cells are considered the least immunogenic. Obtaining viable NK cells with stable phenotypes in quantities sufficient for modification is technologically challenging. The candidate sources include primary mononuclear cell cultures and immortalized NK cell lines; alternatively, the clinical-grade NK cells can be differentiated from induced pluripotent stem cells (iPSCs) by a good manufacturing practice (GMP)-compatible xeno-free protocol. In this review, we analyze existing protocols for targeted differentiation of human iPSCs into NK cells with a focus on xeno-free requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalInduced Pluripotent Stem CellsCell DifferentiationImmunotherapy, AdoptiveHumansCell Culture TechniquesAnimals

Stichwörter der Autor:innen

adoptive NK cell therapyinduced pluripotent stem cellsxeno-free platforms

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, Moskvorechye Str. 1, Moscow 115522, Russia.
  • Research Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia, Miklukho-Maklaya Str. 6, Moscow 117198, Russia.
  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Samory Mashela Str. 1, Moscow 117198, Russia.

ORCID-Profile: Natalia Usman

Förderung

  • Research Institute of Molecular and Cellular Medicine, Peoples’ Friendship University of Russia
  • the state assignment of the Federal State Funded Research Institution “Research Centre for Medical Genetics”

Zitieren

APA

Budagova, T., Efremova, A., Usman, N., Mokrousova, D., & Goldshtein, D. (2025). Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031107

Vancouver

Budagova T, Efremova A, Usman N, Mokrousova D, Goldshtein D. Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031107

BibTeX
@article{Budagova2025,
  author = {Budagova, Tatiana and Efremova, Anna and Usman, Natalia and Mokrousova, Diana and Goldshtein, Dmitry},
  title = {Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031107}
}
Kostenlos starten →